Search research articles
Contact Us
Filters
Showing results (1-10 of 121) with videos related to
Page
of 13
Sort By:
Alimentary Pharmacology & Therapeutics
|
July 15, 2023
Editorial: MTTP, hepatic steatosis and plasma lipids - still more questions than answers
Vincent L Chen
Alimentary Pharmacology & Therapeutics
|
June 26, 2024
Editorial: Genetics for non-invasive risk stratification-Finding the needle in the haystack?
Vincent L Chen
Alimentary Pharmacology & Therapeutics
|
July 30, 2025
Editorial: Accelerometers to Quantify Physical Activity in MASLD-Impact on Clinical Outcomes
Vincent L Chen
Alimentary Pharmacology & Therapeutics
|
September 4, 2025
Editorial: Time to Genotype-Genetic Risk and Prognosis in Steatotic Liver Disease. Authors' Reply
Matthew Kubina, Vincent L Chen
Seminars in Liver Disease
|
April 27, 2023
Screening for At-Risk Nonalcoholic Fatty Liver Disease in the Primary Care Setting
Esteban Urias, Vincent L Chen
Alimentary Pharmacology & Therapeutics
|
February 24, 2025
Editorial: Lipidomics in MASLD and MetALD
Rajalakshmi Govalan, Vincent L Chen
Clinics in Liver Disease
|
October 5, 2020
Role of Biomarkers and Biopsy in Hepatocellular Carcinoma
Vincent L Chen, Pratima Sharma
Current Opinion in Gastroenterology
|
March 30, 2026
Precision medicine in steatotic liver disease
Vitchapong Prasitsumrit, Vincent L Chen
Alimentary Pharmacology & Therapeutics
|
March 6, 2026
Editorial: Genotyping for Hepatocellular Carcinoma Risk Stratification in the General Population
Vitchapong Prasitsumrit, Vincent L Chen
Liver International : Official Journal of the International Association for the Study of the Liver
|
July 21, 2020
Author response to Letter to the Editor: 'Chronological change in alpha-foetoprotein levels in hepatocellular carcinoma after eradication of hepatitis C virus'
Vincent L Chen, Neehar D Parikh
Page
of 13
Search research articles
Search
Showing results (1-10 of 121) with videos related to
Sort By:
Page
of 13
Alimentary Pharmacology & Therapeutics
|
July 15, 2023
Editorial: MTTP, hepatic steatosis and plasma lipids - still more questions than answers
Vincent L Chen
Alimentary Pharmacology & Therapeutics
|
June 26, 2024
Editorial: Genetics for non-invasive risk stratification-Finding the needle in the haystack?
Vincent L Chen
Alimentary Pharmacology & Therapeutics
|
July 30, 2025
Editorial: Accelerometers to Quantify Physical Activity in MASLD-Impact on Clinical Outcomes
Vincent L Chen
Alimentary Pharmacology & Therapeutics
|
September 4, 2025
Editorial: Time to Genotype-Genetic Risk and Prognosis in Steatotic Liver Disease. Authors' Reply
Matthew Kubina, Vincent L Chen
Seminars in Liver Disease
|
April 27, 2023
Screening for At-Risk Nonalcoholic Fatty Liver Disease in the Primary Care Setting
Esteban Urias, Vincent L Chen
Alimentary Pharmacology & Therapeutics
|
February 24, 2025
Editorial: Lipidomics in MASLD and MetALD
Rajalakshmi Govalan, Vincent L Chen
Clinics in Liver Disease
|
October 5, 2020
Role of Biomarkers and Biopsy in Hepatocellular Carcinoma
Vincent L Chen, Pratima Sharma
Current Opinion in Gastroenterology
|
March 30, 2026
Precision medicine in steatotic liver disease
Vitchapong Prasitsumrit, Vincent L Chen
Alimentary Pharmacology & Therapeutics
|
March 6, 2026
Editorial: Genotyping for Hepatocellular Carcinoma Risk Stratification in the General Population
Vitchapong Prasitsumrit, Vincent L Chen
Liver International : Official Journal of the International Association for the Study of the Liver
|
July 21, 2020
Author response to Letter to the Editor: 'Chronological change in alpha-foetoprotein levels in hepatocellular carcinoma after eradication of hepatitis C virus'
Vincent L Chen, Neehar D Parikh
Page
of 13